ARHGAP31 and prostate cancer: Kaplan–Meier analyses demonstrated that high CdGAP cytoplasmic intensity in cancer cells was associated with a trend toward increased risk of developing bone metastasis in prostate cancer patients (p = 0.057; Fig. 8k).